Navigation Links
Inflection Biosciences licenses preclinical oncology programs from the CNIO
Date:6/4/2013

Inflection Biosciences Ltd, a private company focused on the development of targeted small molecule treatments for cancer, today announced that it has entered into a license agreement with the Spanish National Cancer Research Centre (CNIO) for the exclusive, worldwide rights to develop and commercialise several novel kinase inhibitors for the treatment of cancer.

The compounds leverage the CNIO's considerable expertise in drug discovery and comprise a novel pan-PIM kinase inhibitor program and a number of unique multi-targeting kinase inhibitors combining activity on PIM kinase and additional kinases including the phosphoinositide-3 kinase and the mammalian target of rapamycin (PI3K/mTOR) pathway. All molecules have shown good activity in preclinical models, are orally- available with excellent pharmaceutical properties.

Dr María Blasco, Director of CNIO added "It is a great satisfaction for the CNIO to join forces with the experienced team at Inflection Biosciences, allowing us to take full advantage of our ability to innovate cancer treatments."

Dr Michael O'Neill, Co-Founder and Director of Research and Development at Inflection Biosciences commented "Following an extensive global search we are delighted to have secured assets in late preclinical stages of development of this quality and potential and from an organisation recognised internationally for the quality of its cancer research and its drug discovery programs."


'/>"/>

Contact: Press Office
comunicacion@cnio.es
Centro Nacional de Investigaciones Oncologicas (CNIO)
Source:Eurekalert

Page: 1

Related biology news :

1. HUNT Biosciences and SomaLogic collaborate to validate protein biomarkers of cardiovascular risk
2. Amarantus BioSciences to Present at the National Investment Banking Associations (NIBA)122nd Conference in New York City
3. 3-V Biosciences Appoints Douglas I. Buckley, PhD, as Vice President of Biology
4. Althea Technologies & Profectus BioSciences Sign Manufacturing Agreement For Plasmid DNA Production
5. Ben-Gurion U. licenses drug delivery platform for central nervous system diseases to NY biotech firm
6. Collaborative preclinical efficacy studies suggest a new target for drug addiction treatment
7. Preclinical studies use specialized ultrasound to detect presence of cancer
8. Preclinical study shows potential of new technologies to detect response to cancer therapy earlier
9. AACR news: Paragazole excels in preclinical models of triple-negative breast cancer
10. ESMO 2012 Congress: A path for medical oncology innovations
11. TGen-US Oncology data guides treatment of metastatic triple-negative breast cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/8/2019)... ... September 06, 2019 , ... RoosterBio, ... stem/stromal cell (hMSC) biomanufacturing systems, today announces its release of the Regenerative ... system designed for product development. RoosterBio continues to simplify MSC production by ...
(Date:8/29/2019)... ... August 29, 2019 , ... ... breakthrough spinal robotics platform in an upcoming episode, which is scheduled to broadcast ... design, development, and commercialization of cost-effective robotic surgical solutions for the treatment of ...
(Date:8/27/2019)... ... August 26, 2019 , ... Shoreline Biome , a ... level, has hired Bill McKenzie as its CEO and Karen Woodward as its VP ... Biome meet growing demand for its products and expand the company’s sales worldwide. , ...
Breaking Biology News(10 mins):
(Date:8/29/2019)... ... 28, 2019 , ... DuPont Nutrition & Biosciences will offer ... the International Baking Industry Expo, September 8 to 11, in booth 5015. DuPont ... cost and waste reduction and from maintaining freshness throughout shelf life to reformulating ...
(Date:8/27/2019)... ... 27, 2019 , ... Modality Solutions , an Inc. ... Consulting Engineer, Robert Battista, to Senior Consulting engineer. , In his new leadership ... new engineers as well as the creation of additional business opportunities and cutting-edge ...
(Date:8/23/2019)... ... August 22, 2019 , ... An upcoming episode of ... to broadcast 4Q/2019. Check your local listings for more information. , This segment ... delivery. Focusing on therapeutics for children and the elderly, viewers will learn about ...
(Date:8/14/2019)... ... August 13, 2019 , ... ... focus on prepackaged mobile phases for QC laboratories. After gaining a few significant ... laboratory sciences approach into a valued supplier of manufacturing processing solutions, including reagents ...
Breaking Biology Technology: